US health insurance is an obstacle to disease-modifying treatments in MS.

Bourdette, Dennis

US health insurance is an obstacle to disease-modifying treatments in MS. [electronic resource] - Neurology 07 2016 - 346-7 p. digital

Publication Type: Editorial

1526-632X

10.1212/WNL.0000000000002904 doi


Humans
Immunomodulation
Insurance, Health--economics
Multiple Sclerosis, Relapsing-Remitting--drug therapy
United States